Four Biotech IPOs Raise $1.5B in April, the Biggest Month in Five Years

Hemab Therapeutics and Seaport Therapeutics are the latest biotech firms to hitch the general public markets, every with an upsized IPO. In response to IPO analysis agency Renaissance Capital, April was the most important month for biotech IPO proceeds in additional than 5 years.

The submit 4 Biotech IPOs Increase $1.5B in April, the Greatest Month in 5 Years appeared first on MedCity Information.

Source link